Immuneering Corporation (IMRX)
NASDAQ: IMRX · IEX Real-Time Price · USD
1.110
-0.030 (-2.63%)
At close: Jul 19, 2024, 4:00 PM
1.100
-0.010 (-0.90%)
Pre-market: Jul 22, 2024, 4:26 AM EDT
Immuneering Market Cap
Immuneering has a market cap or net worth of $32.92 million as of July 22, 2024. Its market cap has decreased by -88.65% in one year.
Market Cap
32.92M
Enterprise Value
-33.98M
1-Year Change
-88.65%
Ranking
Category
Stock Price
$1.11
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $32.92M, a decrease of -91.00%. That is a compound annual growth rate of -55.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 32.90M | -84.70% |
| Dec 29, 2023 | 215.10M | 67.92% |
| Dec 30, 2022 | 128.10M | -69.46% |
| Dec 31, 2021 | 419.50M | 14.67% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exagen | 34.05M |
| Nutex Health | 33.88M |
| Retractable Technologies | 33.53M |
| Holdco Nuvo Group D.G | 33.43M |
| Orgenesis | 33.05M |
| ReWalk Robotics | 32.69M |
| ImmuCell | 32.50M |
| Quince Therapeutics | 32.41M |